EMIS offers washable keyboards with systems

  • 20 September 2005

 

Primary care systems supplier, EMIS, has started to offer washable computer keyboards as standard with its systems.

The move comes as concern grows that the so-called ‘superbug’, methicillin resistant Staphyloccocus aureus (MRSA), which causes serious infections in vulnerable patients, can survive and be transmitted on keyboards.

Standard keyboards are easily damaged by liquid spills. A new generation of washable keyboards is emerging but their higher cost is a problem in NHS setting where thousands of replacements might be needed.

EMIS says that the keyboard it has chosen, marketed by an associated division of EMIS, Egton, and protected by a technology called SpillSeal, costs the same as a conventional keyboard. It does, however, stand up to washing in chemical disinfectants.

The Unotron Spillseal keyboards, which can be used with a SmartRest smartcard reader – also washable – cost £30. Egton is making the keyboards available to hospitals as well as marketing them to EMIS’ primary care customers.

The keyboards have been tested by Dr Tony Moore, head of microbiology at Direct Laboratories, Wolverhampton. Results showed that most of the Staphylococcus aureus placed on the keyboards in laboratory conditions was removed with water, but that chemical disinfection was essential to remove the optimum amount of the bacteria.

He reports: “The results suggest that the use and regular disinfection of SpillSeal keyboards within the NHS could assist in reducing the spread of MRSA.”

Related article

Easy clean keyboard could reduce MRSA risk

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

VR project aims to improve mental health for homeless

VR project aims to improve mental health for homeless

A virtual reality initiative has been launched to help homeless people improve their mental health and prepare for independent living.
Virtual ward company Doccla secures £35m in Series B funding

Virtual ward company Doccla secures £35m in Series B funding

Virtual ward and remote monitoring technology provider Doccla has announced that it has secured £35 million in Series B funding.
DigitalHealth.London reveals latest Accelerator programme cohort

DigitalHealth.London reveals latest Accelerator programme cohort

DigitalHealth.London has announced the latest 17 digital health companies selected for its accelerator programme.